TTNP

Titan Pharmaceuticals Stock Price

0.30
0.002 (0.67%)
Upgrade to Real-Time
Afterhours (Closed)
0.30
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.002 0.67% 0.30 0.293 0.30 0.30 0.298 19:26:19
Bid Price Ask Price Spread Spread % News
0.2968 0.30 0.0032 1.07% 2 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,472 3,115,562 $ 0.2962008 $ 922,832 6,069,284 0.14 - 0.7446
Last Trade Time Type Quantity Stock Price Currency
19:46:49 formt 500 $ 0.30 USD

Titan Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 28.70M 95.66M 95.38M $ 3.61M $ - -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 3.10%

more financials information »

Titan Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TTNP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.29980.31770.2850.30179993,750,0970.00020.07%
1 Month0.2860.3970.2830.32007425,470,6260.0144.9%
3 Months0.26880.46880.2580.341182510,692,6960.031211.61%
6 Months0.280.5450.18530.313416111,590,7240.027.14%
1 Year0.740.74460.140.29094519,768,236-0.44-59.46%
3 Years9.6017.100.140.79838014,378,973-9.30-96.88%
5 Years4.2660.000.141.602,717,689-3.96-92.96%

Titan Pharmaceuticals Description

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.


Your Recent History
NASDAQ
TTNP
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.